Literature DB >> 15834758

Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.

M Soyka1, W Koch, H J Möller, T Rüther, K Tatsch.   

Abstract

We report results of a FDG-PET study in 10 patients with schizophrenia (6 unmedicated, 4 never medicated) and 12 healthy age-matched controls. The patients met ICD-10 and DSM-IV criteria for schizophrenia and all reported psychotic, "positive" symptoms when tested. Schizophrenic patients had higher absolute CMRGlu values in almost all quantified regions compared to normal subjects. Using the occipital cortex as the reference region patients showed a hyperfrontal metabolic pattern. Other significant regional differences were found with respect to thalamus, striatum and temporal cortex. The finding of a hyperfrontality in un- and never medicated psychotic schizophrenic patients must be discussed in the light of the psychopathological symptoms of patients when tested, a possible disruption of cortico-striato-thalamic feedback loops and recent findings of a hyperfrontality in experimentally induced psychosis (ketamine- and psilocybin-model of schizophrenia).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834758     DOI: 10.1007/s00406-005-0563-0

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  49 in total

1.  The Lexington narcotic farm.

Authors:  Thomas R Kosten; David A Gorelick
Journal:  Am J Psychiatry       Date:  2002-01       Impact factor: 18.112

2.  FDG-PET and IBZM-SPECT suggest reduced thalamic activity but no dopaminergic dysfunction in chronic alcohol hallucinosis.

Authors:  M Soyka; T Zetzsche; S Dresel; K Tatsch
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2000       Impact factor: 2.198

3.  Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia.

Authors:  K F Berman; E F Torrey; D G Daniel; D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  1992-12

4.  Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: a pilot study.

Authors:  I Berman; A Merson; C Sison; E Allan; C Schaefer; M Loberboym; M F Losonczy
Journal:  Psychopharmacol Bull       Date:  1996

5.  Hypofrontality in neuroleptic-naive schizophrenic patients during the Wisconsin Card Sorting Test--a fMRI study.

Authors:  S Riehemann; H P Volz; P Stützer; S Smesny; C Gaser; H Sauer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2001       Impact factor: 5.270

6.  Positron emission tomography in schizophrenic patients with and without neuroleptic medication.

Authors:  L E DeLisi; H H Holcomb; R M Cohen; D Pickar; W Carpenter; J M Morihisa; A C King; R Kessler; M S Buchsbaum
Journal:  J Cereb Blood Flow Metab       Date:  1985-06       Impact factor: 6.200

7.  Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs.

Authors:  M H Chakos; J A Lieberman; R M Bilder; M Borenstein; G Lerner; B Bogerts; H Wu; B Kinon; M Ashtari
Journal:  Am J Psychiatry       Date:  1994-10       Impact factor: 18.112

8.  Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort.

Authors:  K F Berman; R F Zec; D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  1986-02

9.  Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia.

Authors:  H Szechtman; C Nahmias; E S Garnett; G Firnau; G M Brown; R D Kaplan; J M Cleghorn
Journal:  Arch Gen Psychiatry       Date:  1988-06

10.  Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics.

Authors:  M S Buchsbaum; R J Haier; S G Potkin; K Nuechterlein; H S Bracha; M Katz; J Lohr; J Wu; S Lottenberg; P A Jerabek
Journal:  Arch Gen Psychiatry       Date:  1992-12
View more
  17 in total

1.  Energization by multiple substrates and calcium challenge reveal dysfunctions in brain mitochondria in a model related to acute psychosis.

Authors:  Jamila Monteiro; Gabriela Assis-de-Lemos; Eduardo de-Souza-Ferreira; Adriana M Marques; Gilda A Neves; Mariana S Silveira; Antonio Galina
Journal:  J Bioenerg Biomembr       Date:  2019-12-18       Impact factor: 2.945

Review 2.  Delta frequency optogenetic stimulation of the thalamic nucleus reuniens is sufficient to produce working memory deficits: relevance to schizophrenia.

Authors:  Aranda R Duan; Carmen Varela; Yuchun Zhang; Yinghua Shen; Lealia Xiong; Matthew A Wilson; John Lisman
Journal:  Biol Psychiatry       Date:  2015-02-28       Impact factor: 13.382

3.  Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit.

Authors:  Alessandro Gozzi; Valerio Crestan; Giuliano Turrini; Marcel Clemens; Angelo Bifone
Journal:  Psychopharmacology (Berl)       Date:  2010-01-29       Impact factor: 4.530

Review 4.  A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia.

Authors:  John E Lisman; Hyun Jae Pi; Yuchun Zhang; Nonna A Otmakhova
Journal:  Biol Psychiatry       Date:  2010-05-31       Impact factor: 13.382

5.  Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia.

Authors:  Inna Gaisler-Salomon; Gretchen M Miller; Nao Chuhma; Sooyeon Lee; Hong Zhang; Farhad Ghoddoussi; Nicole Lewandowski; Stephen Fairhurst; Yvonne Wang; Agnès Conjard-Duplany; Justine Masson; Peter Balsam; René Hen; Ottavio Arancio; Matthew P Galloway; Holly M Moore; Scott A Small; Stephen Rayport
Journal:  Neuropsychopharmacology       Date:  2009-06-10       Impact factor: 7.853

6.  S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance.

Authors:  Johann Steiner; Aye Mu Myint; Kolja Schiltz; Sabine Westphal; Hans-Gert Bernstein; Martin Walter; Matthias L Schroeter; Markus J Schwarz; Bernhard Bogerts
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-10

7.  Regional brain metabolism in schizophrenia: An FDG-PET study.

Authors:  R Seethalakshmi; S R Parkar; N Nair; S A Adarkar; A G Pandit; S A Batra; N S Baghel; S H Moghe
Journal:  Indian J Psychiatry       Date:  2006-07       Impact factor: 1.759

8.  Global prefrontal and fronto-amygdala dysconnectivity in bipolar I disorder with psychosis history.

Authors:  Alan Anticevic; Margaret S Brumbaugh; Anderson M Winkler; Lauren E Lombardo; Jennifer Barrett; Phillip R Corlett; Hedy Kober; June Gruber; Grega Repovs; Michael W Cole; John H Krystal; Godfrey D Pearlson; David C Glahn
Journal:  Biol Psychiatry       Date:  2012-09-11       Impact factor: 13.382

Review 9.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

10.  Different positron emission tomography findings in schizophrenia and narcolepsy type 1 in adolescents and young adults: a preliminary study.

Authors:  Wei-Chih Chin; Feng-Yuan Liu; Yu-Shu Huang; Ing-Tsung Hsiao; Chih-Huan Wang; Ying-Chun Chen
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.